Coronavirus Outbreak: Govt to grant licence to industrial manufacturers to produce oxygen for medical use Medical Dialogues Bureau8 April 2020 4:30 AM GMTNew Delhi: The Drug Controller General of India (DCGI) has decided to grant a licence to manufacturers of industrial oxygen to produce oxygen for medic...
Roche Diagnostics India first private firm to get COVID-19 test approval Medical Dialogues Bureau20 March 2020 4:30 AM GMTNew Delhi: Roche Diagnostics India has received the license from the country's drug regulator DCGI for its ''Cobas SARS CoV-2'' diagnostic test kit, ma...
Zydus gets DCGI nod for Phase I clinical trial of ZYBK2b to treat Rheumatoid Arthritis Medical Dialogues Bureau4 March 2020 5:04 AM GMTZYBK2 has been specifically designed to inhibit HLA-DRB1 Shared Epitope (SE) that determines the susceptibility of a person to develop rheumatoid...
With questions about safety of Meril's Made in India BVS stent, NPPA defers its appeal for price exemption Medical Dialogues Bureau21 Nov 2019 6:39 AM GMTNew Delhi: With an industry association raising health and safety concerns about the flagship Sirolimus-Eluting BioResorbable vascular scaffold system ...
Dr Reddys gets CDSCO Committee recommendation for approval for additional indications of Desosumab Farhat Nasim26 Oct 2019 9:08 AM GMTRecently, the Hyderabad-based Dr Reddy's Labs presented its proposal before the CDSCO Committee for an additional indication for Denosumab 120 mg/1.7ml...
Mylan moves application with DCGI to launch new TB drug Pretomanid in India Medical Dialogues Bureau16 Oct 2019 10:40 AM GMT'We have submitted the new drug application to the office of DCGI. We are in an advanced stage of discussion and are working with the office of DCGI......
Zydus Cadila wins DCGI nod for marketing rabies drug Twinrab Medical Dialogues Bureau3 Sep 2019 4:30 AM GMT'The novel biologic which will be marketed under the brand name, Twinrab, is indicated in combination with rabies vaccine for rabies post-exposure prop...
CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups Meghna A Singhania22 May 2019 11:55 AM GMTNew Delhi: One of the oldest pharmaceutical and healthcare companies in India, GlaxoSmithKline recently presented before the Subject Expert Committee...
Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine Meghna A Singhania17 March 2019 8:03 AM GMTNew Delhi: In a major setback to Sun Pharmaceuticals Ltd, the drug price regulator the National Pharmaceutical Pricing Authority(NPPA) has refused to...
Setback to Meril Lifesciences MeRess100: NPPA refuses to give relief of price cap exemption for the biodegradable stent Meghna A Singhania5 March 2019 11:31 AM GMTNew Delhi: In a major setback to Meril Lifesciences, the drug price regulator National Pharmaceutical Pricing Authority(NPPA) has refused to give it...
J&J passes asbestos test, allowed to make baby powder in India Farhat Nasim1 March 2019 8:58 AM GMTNEW DELHI: In a major relief to Johnson & Johnson(J&J), no asbestos was found in the baby powder manufactured in Baddi and Mulund plants. The...
NPPA to decide on Merrills Request for price cap exemption for its biodegradable stent Meghna A Singhania3 Feb 2019 5:46 AM GMTNew Delhi: A Year after Abbott's launch of biodegradable stents which was later withdrawn globally, Meril Life Sciences has moved the National...
